These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 14236075)

  • 1. [STUDIES ON THE TRANSPORT AND SOJOURN OF INTRAVENOUSLY ADMINISTERED FAT EMULSIONS].
    SCHWARTZKOPFF W; WAGENER H; GILLERT KE
    Dtsch Med Wochenschr; 1965 Jan; 90():116-21. PubMed ID: 14236075
    [No Abstract]   [Full Text] [Related]  

  • 2. THE ELECTRON-MICROSCOPIC INVESTIGATION OF CHYLOMICRONS AND FAT EMULSIONS FOR INTRAVENOUS USE.
    HALLBERG D; WERSAELL J
    Acta Chir Scand Suppl; 1964; 325():SUPPL 325:23-5. PubMed ID: 14202131
    [No Abstract]   [Full Text] [Related]  

  • 3. Fat transport in abetalipoproteinemia. The effects of repeated infusions of beta-lipoprotein-rich plasma.
    Lees RS; Ahrens EH
    N Engl J Med; 1969 Jun; 280(23):1261-6. PubMed ID: 4976946
    [No Abstract]   [Full Text] [Related]  

  • 4. ELIMINATION OF INTRAVENOUS FAT FROM THE BLOOD STREAM OF THE DOG.
    HALLBERG D
    Acta Chir Scand Suppl; 1964; 65():SUPPL 325:21-2. PubMed ID: 14204301
    [No Abstract]   [Full Text] [Related]  

  • 5. LIPID METABOLISM IN THE EX VIVO PERFUSED LIVER.
    Kern F; Eiseman B; Normell L
    Am J Clin Nutr; 1965 Jan; 16(1):116-22. PubMed ID: 14262106
    [No Abstract]   [Full Text] [Related]  

  • 6. ON THE KINETICS OF THE ELIMINATION OF INTRAVENOUS FAT EMULSION FROM THE BLOOD STREAM IN DOG AND MAN.
    HALLBERG D
    Nutr Dieta Eur Rev Nutr Diet; 1964; 6():237-47. PubMed ID: 14260919
    [No Abstract]   [Full Text] [Related]  

  • 7. Preparation of 131 I-labeled fat emulsions and distribution of the label in serum lipoproteins and lipid classes following intravenous infusion to normal and hyperlipemic subjects.
    Lakshminarayana G; O'Connell PW; Kruger FA; Hamwi GJ; Cornwell DG
    Am J Clin Nutr; 1972 May; 25(5):531-8. PubMed ID: 4336654
    [No Abstract]   [Full Text] [Related]  

  • 8. THE FATE OF CHYLOMICRONS IN RATS TREATED WITH TRITON WR-1339.
    Moore WT; Tidwell HC; Mcpherson JC
    Am J Clin Nutr; 1965 Jan; 16():135-40. PubMed ID: 14262109
    [No Abstract]   [Full Text] [Related]  

  • 9. CHANGES IN PLASMA AND ERYTHROCYTE LIPIDS DURING SHORT-TERM ADMINISTRATION OF INTRAVENOUS FAT EMULSION AND ITS SUBFRACTIONS.
    Iacono JM; Mueller JF; Zellner DC
    Am J Clin Nutr; 1965 Jan; 16():165-72. PubMed ID: 14262112
    [No Abstract]   [Full Text] [Related]  

  • 10. EFFECT OF ORALLY ADMINISTERED FAT ON THE UTILIZATION OF INTRAVENOUS FAT EMULSIONS.
    Geyer RP; Taylor K
    Am J Clin Nutr; 1965 Jan; 16():123-8. PubMed ID: 14262107
    [No Abstract]   [Full Text] [Related]  

  • 11. Tolerance to intravenously administered fat emulsions.
    HARTWIG QL; COTLAR AM; SHELBY JS; ATIK M; COHN I
    Surgery; 1961 Mar; 49():308-12. PubMed ID: 13712035
    [No Abstract]   [Full Text] [Related]  

  • 12. [Apolipoprotein E mobility between plasma lipoproteins in intravenous administration of fat emulsions (MCT, LCT)].
    Steinmetz A; Schwarz S; Richter G
    Infusionsther Transfusionsmed; 1992 Feb; 19(1):32-6. PubMed ID: 1600396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic alterations in surgical patients. IX. The influence of intravenously administered fat emulsions on nitrogen balance in postoperative patients.
    ABBOTT WE; BENSON JW; DAVIS JH; KRIEGER H; LEVEY S
    J Lab Clin Med; 1957 Jan; 49(1):61-8. PubMed ID: 13385577
    [No Abstract]   [Full Text] [Related]  

  • 14. THE THEORETICAL BACKGROUND OF THE INTRAVENOUS NUTRITION WITH FAT EMULSIONS.
    EDGREN B; WRETLIND A
    Nutr Dieta Eur Rev Nutr Diet; 1963; 5():364-86. PubMed ID: 14112470
    [No Abstract]   [Full Text] [Related]  

  • 15. CHANGES IN THE COMPOSITION OF "SYNTHETIC CHYLOMICRONS" AFTER INTRAVENOUS INFUSION IN MAN.
    Iacono JM; Mueller JF; Wendel LP
    Am J Clin Nutr; 1965 Jan; 16():141-5. PubMed ID: 14262110
    [No Abstract]   [Full Text] [Related]  

  • 16. [PLASMATIC MODIFICATIONS CAUSED BY INTRAVENOUS PERFUSIONS OF LIPID EMULSIONS].
    CHAPTAL J; JEAN R; CRASTESDEPAULET A; ROBINET ; GUILLAUMOT R; ROMEU H
    Montp Med; 1964; 66():33-4. PubMed ID: 14266609
    [No Abstract]   [Full Text] [Related]  

  • 17. STUDIES WITH FAT EMULSIONS: METABOLISM OF INTRAVENOUSLY ADMINISTERED C14-TRIPALMITIN.
    Kinsell LW; Michaels GD; Imaichi K
    Am J Clin Nutr; 1965 Jan; 16(1):97-100. PubMed ID: 14270405
    [No Abstract]   [Full Text] [Related]  

  • 18. CLINICAL USE OF INTRAVENOUS FAT EMULSIONS IN SURGICAL PATIENTS EXPERIENCE WITH 1539 INFUSIONS IN 200 PATIENTS.
    JORDAL K
    Nutr Dieta Eur Rev Nutr Diet; 1963; 5():414-29. PubMed ID: 14112474
    [No Abstract]   [Full Text] [Related]  

  • 19. Abnormal lipid composition of chylomicrons in broad-beta disease (type 3hyperlipoproteinemia).
    Hazzard WR; Porte D; Bierman EL
    J Clin Invest; 1970 Oct; 49(10):1853-8. PubMed ID: 5460288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric digestion modifies absorption of butterfat into lymph chylomicrons in rats.
    Lai HC; Ney DM
    J Nutr; 1998 Dec; 128(12):2403-10. PubMed ID: 9868188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.